Citalopram
Product Images NDC 13107-005

4 FDA label images from Aurolife Pharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Citalopram (NDC 13107-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cita-str1 (Cita Str1)

Cita-str1 (Cita Str1)
Chemical structure of the active ingredient Citalopram hydrobromide, showing its molecular framework including aromatic rings, cyano, fluoro, ether, and amine functional groups.*
FDA Label Image

Citalopram Tablets, Usp 100 Tablets (Citlopram Fig1)

Citalopram Tablets, Usp 100 Tablets (Citlopram Fig1)
Label for Citalopram Tablets USP 10 mg, supplied in a container of 100 tablets. The label states the active ingredient as citalopram hydrobromide USP equivalent to 10 mg citalopram base per tablet. Manufactured by Aurolife Pharma LLC, Dayton, NJ for Aurobindo Pharma USA, Inc. The label includes storage instructions and a barcode.*
FDA Label Image

Package Label.principal Disply Panel (20 MG(100's Bottle))

Package Label.principal Disply Panel (20 MG(100's Bottle))
Label for Citalopram Tablets USP 20 mg, containing 100 tablets. Manufactured by Aurolife Pharma LLC and Aurobindo Pharma USA, Inc., Dayton, NJ. The label includes storage instructions, dispensing guidelines, and a barcode. The labeler is Aurolife Pharma LLC.*
FDA Label Image

Package Label.principal Disply Panel (30 MG(100's Bottle))

Package Label.principal Disply Panel (30 MG(100's Bottle))
Label for Citalopram Tablets, USP 40 mg, showing the active ingredient as citalopram hydrobromide USP equivalent to 40 mg citalopram base. The label instructs on storage conditions (20° to 25°C), contains dispensing guidance, and notes the package contains 100 tablets. Manufactured by Aurolife Pharma LLC and for Aurobindo Pharma USA Inc., both located in Dayton, NJ. The label also includes a barcode and revision date of 07/2009.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.